This week, sibling publication The Recorder caught up with Fenwick & West chairman Gordon Davidson to chat about the possibility of a new tech bubble. Davidson doesn't see one forming yet, noting that many of the companies coming to market have substance and sustainable business models unlike some of their predecessors a decade ago.

Julie Allen, cohead of the capital markets group at Proskauer Rose, is advising Sabre on its proposed IPO. SEC filings show that Sabre listed legal fees and expenses related to its IPO at almost $1.7 million. Winston & Strawn partners James Junewicz and David Sakowitz are representing underwriters on the offering led by Stifel Nicolaus and Oppenheimer & Co.

Solazyme: The San Francisco-based biofuel startup raised $198 million with its IPO on Friday. Davis Polk partner Alan Denenberg is advising Solazyme, whose general counsel is Paul Quinlan. SEC filings by the company show that it estimates $2 million in legal fees and expenses related to the IPO. Wilson Sonsini vice chairman Jeffrey Saper, who also advised on the LinkedIn IPO, and partner Allison Spinner are representing underwriters led by Goldman Sachs and Morgan Stanley.